Priveq

Carnegie Investment Bank Norway is proud to have acted as Sole Manager to Priveq in two successful sell downs in CSAM Health Group AS. The sell downs comprised a total of 2.1 million shares equal to 10% of the share capital in CSAM and marks Priveq’s full exit. 

Carnegie congratulates Priveq with a successful journey in CSAM and look forward to continuing our support of Sverre FlatbyEinar Bonnevie and the rest of the CSAM team going forward.

About CSAM 
CSAM has established itself as a leading Nordic niche player and beyond in the specialised eHealth market with a unique blend of best-in-class innovative technology, and outstanding human skills. The company’s diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. CSAM’s commercial headquarters are in Oslo, Norway. The eHealth solutions provider is represented in 10 countries in Europe, Asia, and North America, including a wholly owned software engineering subsidiary in the Philippines.

Related articles

SpinChip Diagnostics ASA
Investment Banking

SpinChip Diagnostics ASA

Carnegie Investment Bank is proud to have acted as Joint Bookrunner in connection with SpinChip Diagnostics ASA’...

Navamedic ASA
Investment Banking

Navamedic ASA

Carnegie Investment Bank acted as Joint Bookrunner in connection with the NOK 95 million placing of...